Successful treatment of refractory adult-onset still's disease with infliximab. A prospective, non-comparative series of four patients

Clinical Rheumatology

Volumn 23, Issue 1, 2004, Pages 45-49

  Kokkinos, Alexander ^a   Iliopoulos, Alexios ^b   Greka, Paraskevi ^a   Efthymiou, Anna ^a   Katsilambros, Nicholas ^a   Sfikakis, Petros P ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b 401 GENERAL MILITARY HOSPITAL OF ATHENS   (Greece)

Author keywords

Glucocorticoid; Infliximab; Methotrexate; Still's disease adult onset; TNF

Indexed keywords

CORTICOSTEROID; GOLD SALT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; NAPROXEN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RIFAMPICIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL OBSERVATION; DISEASE ACTIVITY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HYPERGLYCEMIA; INFLAMMATION; JUVENILE RHEUMATOID ARTHRITIS; MALE; MYOPATHY; ONSET AGE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIRHEUMATIC AGENTS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; MALE; METHOTREXATE; PROSPECTIVE STUDIES; STILL'S DISEASE, ADULT-ONSET; TREATMENT OUTCOME;

EID: 1342347692     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0775-5     Document Type: Article

References (27)

1. Fautrel B, Le Moel G, Saint-Marcoux B et al. (2001) Diagnostic value of ferritin and glycosylated ferritin in adult onset Still's disease. J Rheumatol 28:322-329
2. Wouters JM, van de Putte LB (1986) Adult-onset Still's disease; clinical and laboratory features, treatment and progress of 45 cases. Q J Med 61:1055-1065
3. Sato M, Takeda A, Honzu H, Saku N, Minato N, Kano S (1993) Adult Still's disease with Sjogren's syndrome successfully treated with intravenous pulse methylprednisolone and oral cyclophosphamide. Intern Med 32:730-732
4. Iglesias J, Sathiraju S, Marik PE (1999) Severe systemic inflammatory response syndrome with shock and ARDS resulting from Still's disease: clinical response with high-dose pulse methylprednisolone therapy. Chest 115:1738-1740
5. Kumakura S, Ishikura H, Munemasa S, Adachi T, Murakawa Y, Kobayashi S (1997) Adult onset Still's disease associated hemophagocytosis. J Rheumatol 24:1645-1648
6. Beckham JC, Caldwell DS, Peterson BL et al. (1992) Disease severity in rheumatoid arthritis: relationship of plasma tumor necrosis factor-alpha, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures. J Clin Immunol 12:353-361
7. Mangge H, Kenzian H, Gallistl S et al. (1995) Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes. Arthritis Rheum 38:211-220
8. Lange U, Teichmann J, Stracke H (2000) Correlation between plasma TNF-alpha, IGF-1, biochemical markers of bone metabolism, markers of inflammation/disease activity, and clinical manifestations in ankylosing spondylitis. Eur J Med Res 5:507-511
9. Van Deventer SJH (1997) Tumour necrosis factor and Crohn's disease. Gut 40:443-448
10. Sfikakis PP (2002) Behcet's disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 61 [Suppl 2]:ii51-53
11. Kavanaugh A, St Clair EW, McCune WJ, Braakman T, Lipsky P (2000) Chimeric anti-tumor necrosis factor-alpha monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy. J Rheumatol 27:841-850
12. Lovell DJ, Giannini EH, Reiff A et al. (2000) Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 342:763-769
13. Breban M, Vignon E, Claudepierre P et al. (2002) Efficacy of infliximab in refractory ankylosing spondylitis: results of a six-month open-label study. Rheumatology (Oxford) 41:1280-1285
14. Bell S, Kamm MA (2000) Antibodies to tumor necrosis factor alpha as treatment for Crohn's disease. Lancet 355:858-860
15. Furst DE, Breedveld FC, Kalden JR et al. (2002) Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other rheumatic diseases (May 2002). Ann Rheum Dis 61 [Suppl 2]:ii2-7
16. Hoshino T, Ohta A, Yang D et al. (1998) Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still's disease. J Rheumatol 25:396-398
17. Fujii T, Nojima T, Yasuoka H et al. (2001) Cytokine and immunogenetic profiles in Japanese patients with adult Still's disease. Association with chronic articular disease. Rheumatology (Oxford) 40:1398-1404
18. Yamaguchi M, Ohta A, Tsunematsu T et al. (1992) Preliminary criteria for classification of adult Still's disease. J Rheumatol 19:424-430
19. Furst DE, Cush J, Kaufmann S, Siegel J, Kurth R (2002) Preliminary guidelines for diagnosing and treating tuberculosis in patients with rheumatoid arthritis in immunosuppressive trials or being treated with biological agents. Ann Rheum Dis 61[Suppl 2]:ii62-63
20. Reference omitted
21. Hanauer SB, Sandborn W, Practice Parameters Committee of the American College of Gastroenterology (2001) Management of Crohn's disease in adults. Am J Gastroenterol 96:635-643
22. Cavagna L, Caporali R, Epis O, Bobbio-Pallavicini F, Montecucco C (2001) Infliximab in the treatment of adult Still's disease refractory to conventional therapy. Clin Exp Rheumatol 19:329-332
23. Kraetsch HG, Antoni C, Kalden JR, Manger B (2001) Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences. Ann Rheum Dis 60 [Suppl 3]:iii55-57
24. Huffstutter JE, Sienknecht CW (2002) Treatment of resistant Adult Still's disease with infliximab-A report of two cases. Arthritis Rheum 46[Suppl]:326
25. Caramaschi P, Biasi D, Carletto A, Bambara LM (2002) A case of adult onset Still's disease treated with infliximab. Clin Exp Rheumatol 20:113
26. Husni ME, Maier AL, Mease PJ et al. (2002) Etanercept in the treatment of adult patients with Still's disease. Arthritis Rheum 46:1171-1176
27. Van Deventer SJH (2001) Transmembrane TNF-a, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's disease. Gastroenterology 121:1242-1246